Partner Headlines - SLXP

  1. Top Funds Buying Rackspace, Allergan ogen Idec, Apple

    IBD
  2. Must Watch Stocks for Today

    Benzinga
  3. Earnings Scheduled For March 2, 2015

    Benzinga
  4. Jazz Pharmaceuticals Tops Q4 Earnings And Tests Buy Point

    IBD
  5. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD
  6. Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price ...

    Benzinga
  7. Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity

    Benzinga
  8. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD
  9. Firms Bullish On Valeant Following Earnings, Acquisition

    Benzinga
  10. Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals

    GuruFocus
  11. Benzinga's Top Downgrades

    Benzinga
  12. UBS Downgrades Salix Pharmaceuticals To Neutral

    Benzinga
  13. 4 Pictures Every Valeant-Salix Investor Should See

    Benzinga
  14. Taxes Put U.S. Firms On Sale

    IBD
  15. Tax System Gives Edge To Foreign Buys Of U.S. Firms

    IBD
  16. Bristol-Myers goes for the gut

    IBD
  17. Nasdaq Stretches Win Streak To 9 Days

    IBD
  18. Nasdaq Climbs As Apple Stock Hits New High

    IBD
  19. Biotech Stocks Moving Higher

    Benzinga
  20. Fast Money Halftime Report Final Trade From February 23

    Benzinga
  21. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD
  22. JMP Securities Comments On Salix Pharmaceutical's Takeover Valuation

    Benzinga
  23. Valeant CEO Explains Why The Company Is Acquiring Salix For $1 ...

    Benzinga
  24. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD
  25. Stocks Edge Lower, Oil Falls, But Managed-Care Firms Shine

    IBD
  26. Cramer: Valeant's Stock Doesn't Stop Here, It Goes Higher

    Benzinga
  27. Stocks Open Quietly in The Red; Nationstar, Valeant, Tower Rise

    IBD
  28. Benzinga's Volume Movers

    Benzinga
  29. Morning Market Gainers

    Benzinga
  30. Stock Futures Dip, But Not Much; Valeant, Polypore, AerCap Surge

    IBD
  31. Piper Jaffray Downgrades Salix Pharmaceuticals To Neutral

    Benzinga
  32. Benzinga's Top Downgrades

    Benzinga
  33. US Stock Futures Slip Ahead Of Economic Data

    Benzinga
  34. Must Watch Stocks for Today

    Benzinga
  35. Fast Money Halftime Report Final Trade From February 20

    Benzinga
  36. Valeant Pharmaceuticals Will Buy Salix For $14.5 Billion

    IBD
  37. Benzinga's Weekend M&A Chatter

    Benzinga
  38. John Paulson's Top Buys

    GuruFocus
  39. A Look At 5 IBD 50 Stocks With Upcoming Earnings

    IBD
  40. Valeant Pharmaceuticals

    IBD
  41. Great Stocks Often Have Smooth, Symmetrical Bases

    IBD
  42. Stocks Cap Short Week With Gains; Salix Up On Buyout Hopes

    IBD
  43. Greek Deal Lifts Nasdaq Near Dot-Com Bubble High

    IBD
  44. Boeing Lifts Dow; Nasdaq Gets Apple Boost

    IBD
  45. Market Turns Positive As Stocks Stage Reversal

    IBD
  46. Medical Stocks Rise; Valeant Said To Be Near Buy Of Salix

    IBD
  47. Novo Nordisk Pops On Successful Diabetes Drug Trial

    IBD
  48. John Paulson Chooses Energy, Semiconductor and Drug Stocks in ...

    GuruFocus
  49. Fourth-Quarter Acquisitions Rearrange Jana Partners' Portfolio

    GuruFocus
  50. Paulson & Company's Q4 Moves: Healthcare And Beyond

    Benzinga
  51. Benzinga's Weekend M&A Chatter

    Benzinga
  52. Three Pharma Majors In The Run To Acquire Salix

    GuruFocus
  53. Salix, Top Drug Stocks Rally As Merger Mania Heats Up

    IBD
  54. Sterne Agee Dives Deep Into 3 Biotechs

    Benzinga
  55. Benzinga's M&A Chatter for Thursday February 12, 2015

    Benzinga
  56. Volume Rises As Stocks Trade Near Session High

    IBD
  57. Shire Moves Higher On NPS Potential; Q4 Earnings Miss

    IBD
  58. Benzinga's M&A Chatter for Tuesday February 3, 2015

    Benzinga
  59. Valeant Could Be Interested In Buying Salix; Sterne Agree Says ...

    Benzinga
  60. Stocks On Pace For Second Straight Gain; Salix Rallies

    IBD
  61. Benzinga's M&A Chatter for Tuesday January 20, 2015

    Benzinga
  62. Salix Pharmaceuticals

    IBD
  63. Report: Salix Pharmaceuticals Exploring Possible Sale

    Benzinga
  64. Salix Pharma Reportedly Exploring Sale; Stock Up

    IBD
  65. Jefferies Weighs In On Specialty Pharmaceuticals After Management ...

    Benzinga
  66. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  67. Stocks Mixed As Early Strength Fades; Salix Jumps

    IBD
  68. SALIX

    IBD
  69. Benzinga's M&A Chatter for Thursday December 18, 2014

    Benzinga
  70. Credit Suisse Raises Salix Pharmaceuticals Price Target

    Benzinga
  71. Salix rebounding from crash

    IBD
  72. Salix Destocking Plan, 2-Year Guidance Soothe Street

    IBD
  73. #PreMarket Movers From December 16, 2014

    Benzinga
  74. Pharmaceutical Giant Merck Buys Cubist Pharma

    GuruFocus
  75. Sterne Agee Says Salix Pharmaceuticals Accounting Concerns Are ...

    Benzinga
  76. How Adam Feuerstein Follows The Biotech Sector

    Benzinga
  77. Deutsche Bank Slashes Price Target On Salix Pharmaceuticals

    Benzinga
  78. U.S. Produced Fewer Than Expected Jobs In October

    Benzinga
  79. Health Sell-Offs Drag On IBD 50

    IBD
  80. Dow, S&P 500 Flirt With Record, But Finish Just Off

    IBD
  81. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  82. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  83. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  84. Mid-Day Market Update: Allscripts Healthcare Slides On Downbeat ...

    Benzinga
  85. Mid-Morning Market Update: Markets Edge Lower; Humana Profit ...

    Benzinga
  86. Jefferies Sees Acquisition Of Salix Pharmaceuticals As Being ...

    Benzinga
  87. Morning Market Losers

    Benzinga
  88. Benzinga's Top Downgrades

    Benzinga
  89. Stocks Set For Higher Start After Mixed Jobs Report

    IBD
  90. Stifel Nicolaus Downgrades Salix Pharmaceuticals To Hold

    Benzinga
  91. Benzinga's Top #PreMarket Losers

    Benzinga
  92. UPDATE: Stifel Downgrades Salix Pharmaceuticals As Uncovered ...

    Benzinga
  93. Salix Dives On Earnings, Probe; Akorn A Bad Seed Too

    IBD
  94. Salix Dives On Miss, Probe

    IBD
  95. Indexes Higher; El Pollo Loco Reports In Line

    IBD
  96. Stocks Cling To Modest Gains; Advance Auto Rebounds

    IBD
  97. Stocks Down As Early Gains Fade; Generac Dives, Tableau Soars

    IBD
  98. Earnings Scheduled For November 6, 2014

    Benzinga
  99. 3 IBD 50 Tech, Drug Stocks With Earnings Thursday

    IBD
  100. Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap

    IBD
Trading Center